SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aviron
AVIR 3.065+1.2%Nov 26 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Haolin Ni who wrote (41)7/29/1997
From: Rick Strange   of 645
 
Brad cited the NIH as the source of the figure of 20,000 deaths per year attributed to influenza that I quoted before. The operative word is attributed.

It is true that the influenza virus itself is not the killer but rather a causitive agent that sets the stage for more opportunistic agents or in tandum with preexisting conditions overwhelm the patient.

I cite another source of the lethal aspects of influenza from the World Health Organization:
who.ch

"Major influenza pandemics have occurred at least three times each century, infecting hundreds of millions of people, and killing millions.

The influenza pandemic of 1918 was the largest in recent history, causing 20-40 million deaths worldwide. More recently, the 1957 and 1968 influenza pandemics have killed a million people. During the Hong Kong pandemic of 1968, mortality in the USA alone was estimated at around 30,000 deaths, 51 million Americans were ill and the total economic burden was US$3.9 million.

Neither the "anigentic drift" or the "antigentic shift" impact AVIR's
technology. They will manufacture vaccine for the three viral strains established each year by WHO and NIH. Yes, the vaccine will differ from year to year but every manufacture is on a level playing field in that they must change the formulation also. I fail to see where this is a meaningful issue.

Finally, there are nearly 70 million children that do not currently get influenza vaccinations each year in the USA. It is estimated that one third of these will come down with flu like illnesses each year. If AVIR gets approval for its vaccine I can invision each child getting a spray of vaccine up his/her nose at school. This would nearly double the influenza vaccine market.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News